Received Rs.2.84 Crore PO from M/s. Chowgule for satcom products; delivery by March 15, 2026; 24-month warranty.
2 Likes
Avantel Q2 results are out:
Summery:
Q2 FY26 results show sequential growth but YoY decline, reflecting order execution timing differences.
Margins remain solid despite ESOP-related expenses and expansion investments.
The company continues strengthening its balance sheet and investing in capacity expansion and R&D.
Balance Sheet Highlights (Standalone)
- Total Assets: ₹40,158.59 lakh (vs ₹29,775.65 lakh in Mar 2025)
- Equity Share Capital: ₹5,299.45 lakh
- Other Equity: ₹28,471.20 lakh
- Net Worth: ₹33,770.65 lakh
- Borrowings (Total): ₹3,919.01 lakh
Cash Flow (Standalone, H1 FY26)
- Operating Cash Flow: +₹682.37 lakh
- Investing Activities: (₹8,757.57 lakh) – major capex
- Financing Activities: +₹8,283.22 lakh – primarily from share issue proceeds
- Closing Cash: ₹366.37 lakh
Key Notes
- ESOP Expense: ₹177.57 lakh in Q2; ₹324.97 lakh for H1 FY26.
- 7,600 equity shares allotted to employees under the Avantel ESOP 2023 during the quarter.
- Segment Revenue (Consolidated):
- Communications & Signal Processing: ₹5,603.36 lakh
- Healthcare: ₹29.43 lakh (subsidiary iMeds Global Pvt. Ltd.)
- Subsidiary iMeds Global Pvt. Ltd. reported a loss of ₹190.4 lakh in Q2.
- No material auditor observations — Limited Review Reports express no adverse findings.
4 Likes
is the current PE of 125 concerning? i understand we have guidance of higher revenue in FY27 & FY28.